However, depletion of MDSCs from tumor-bearing mice by anti-Gr-1 Ab treatment failed to show tumor regression in the CT26/HER2 model, suggesting that MDSCs may not have the ability to block the induction of tumor regression in this model. The gene discussed is ERBB2; the disease is neoplasm.